JHCP
ELV icon

Jackson Hole Capital Partners’s Elevance Health ELV Stock Holding History

Jackson Hole Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.52M Buy
5,197
+63
+1% +$20.7K 0.25% 93
2025
Q4 		$1.8M Sell
5,134
-569
-10% -$192K 0.31% 84
2025
Q3 		$1.84M Sell
5,703
-299
-5% -$93K 0.32% 90
2025
Q2 		$2.33M Sell
6,002
-1
-0% -$402 0.43% 73
2025
Q1 		$2.61M Sell
6,003
-26
-0.4% -$10.4K 0.52% 60
2024
Q4 		$2.22M Sell
6,029
-133
-2% -$55.7K 0.45% 66
2024
Q3 		$3.2M Buy
6,162
+43
+0.7% +$23K 0.67% 42
2024
Q2 		$3.32M Buy
6,119
+55
+0.9% +$29.1K 0.72% 37
2024
Q1 		$3.14M Buy
6,064
+393
+7% +$195K 0.71% 39
2023
Q4 		$2.67M Buy
5,671
+650
+13% +$301K 0.68% 37
2023
Q3 		$2.19M Sell
5,021
-166
-3% -$75.3K 0.64% 40
2023
Q2 		$2.3M Sell
5,187
-489
-9% -$226K 0.63% 40
2023
Q1 		$2.62M Buy
5,676
+430
+8% +$205K 0.69% 38
2022
Q4 		$2.69M Sell
5,246
-181
-3% -$91.9K 0.8% 35
2022
Q3 		$2.46M Buy
5,427
+75
+1% +$35.9K 0.76% 37
2022
Q2 		$2.58M Sell
5,352
-87
-2% -$43K 0.81% 36
2022
Q1 		$2.67M Buy
5,439
+173
+3% +$79.1K 0.77% 38
2021
Q4 		$2.44M Sell
5,266
-161
-3% -$67.7K 0.76% 38
2021
Q3 		$2.02M Buy
5,427
+296
+6% +$112K 0.66% 50
2021
Q2 		$1.96M Buy
5,131
+58
+1% +$22.2K 0.68% 48
2021
Q1 		$1.82M Buy
5,073
+249
+5% +$80.1K 0.75% 42
2020
Q4 		$1.55M Buy
4,824
+279
+6% +$85.6K 0.71% 49
2020
Q3 		$1.22M Buy
4,545
+259
+6% +$69.7K 0.64% 52
2020
Q2 		$1.13M Buy
4,286
+219
+5% +$58.4K 0.69% 47
2020
Q1 		$923K Buy
+4,067
New +$1.11M 0.69% 51

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Jackson Hole Capital Partners's ELV Position: Q1 2026 in Review

Jackson Hole Capital Partners increased its Elevance Health (ELV) stake by 1.2% in Q1 2026, buying an estimated $20.7K and bringing the position to 5,197 shares worth $1.52M. The position accounts for 0.25% of the portfolio, ranked #93.

Jackson Hole Capital Partners first reported a position in ELV in Q1 2020 and has held it in 25 quarters since. The position peaked at $3.32M in Q2 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Jackson Hole Capital Partners held 5,197 shares of Elevance Health worth $1.52M as of Q1 2026.
  • Jackson Hole Capital Partners bought 63 Elevance Health shares in Q1 2026, an estimated $20.7K.
  • Elevance Health made up 0.25% of Jackson Hole Capital Partners's portfolio in Q1 2026, its #93 holding.
  • Jackson Hole Capital Partners first reported a position in Elevance Health in Q1 2020 and has held it in 25 quarters since.
  • Jackson Hole Capital Partners's Elevance Health position peaked at $3.32M in Q2 2024.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Jackson Hole Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.